These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 35099487)
1. Metal-based anticancer agents as immunogenic cell death inducers: the past, present, and future. Sen S; Won M; Levine MS; Noh Y; Sedgwick AC; Kim JS; Sessler JL; Arambula JF Chem Soc Rev; 2022 Feb; 51(4):1212-1233. PubMed ID: 35099487 [TBL] [Abstract][Full Text] [Related]
2. Rediscovery of nanoparticle-based therapeutics: boosting immunogenic cell death for potential application in cancer immunotherapy. Yang S; Sun IC; Hwang HS; Shim MK; Yoon HY; Kim K J Mater Chem B; 2021 May; 9(19):3983-4001. PubMed ID: 33909000 [TBL] [Abstract][Full Text] [Related]
3. Natural Compounds of Marine Origin as Inducers of Immunogenic Cell Death (ICD): Potential Role for Cancer Interception and Therapy. Sansone C; Bruno A; Piscitelli C; Baci D; Fontana A; Brunet C; Noonan DM; Albini A Cells; 2021 Jan; 10(2):. PubMed ID: 33504012 [TBL] [Abstract][Full Text] [Related]
4. Immunogenic cell death-inducing metal complexes: From the benchtop to the clinic. Sen S; Karoscik K; Maier E; Arambula JF Curr Opin Chem Biol; 2023 Apr; 73():102277. PubMed ID: 36867977 [TBL] [Abstract][Full Text] [Related]
5. Anticancer metal drugs and immunogenic cell death. Terenzi A; Pirker C; Keppler BK; Berger W J Inorg Biochem; 2016 Dec; 165():71-79. PubMed ID: 27350082 [TBL] [Abstract][Full Text] [Related]
6. Microbes mediated immunogenic cell death in cancer immunotherapy. Huang J; Duan F; Xie C; Xu J; Zhang Y; Wang Y; Tang YP; Leung EL Immunol Rev; 2024 Jan; 321(1):128-142. PubMed ID: 37553793 [TBL] [Abstract][Full Text] [Related]
7. Reinforcing the immunogenic cell death to enhance cancer immunotherapy efficacy. Yu S; Xiao H; Ma L; Zhang J; Zhang J Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188946. PubMed ID: 37385565 [TBL] [Abstract][Full Text] [Related]
8. A Half-Sandwich Ruthenium(II) (N^N) Complex: Inducing Immunogenic Melanoma Cell Death in Vitro and in Vivo. Xu Z; Xu M; Wu X; Guo S; Tian Z; Zhu D; Yang J; Fu J; Li X; Song G; Liu Z; Song X ChemMedChem; 2023 Aug; 18(16):e202300131. PubMed ID: 37226330 [TBL] [Abstract][Full Text] [Related]
9. Targeting immunogenic cell stress and death for cancer therapy. Galluzzi L; Guilbaud E; Schmidt D; Kroemer G; Marincola FM Nat Rev Drug Discov; 2024 Jun; 23(6):445-460. PubMed ID: 38622310 [TBL] [Abstract][Full Text] [Related]
10. Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy. Gao J; Wang WQ; Pei Q; Lord MS; Yu HJ Acta Pharmacol Sin; 2020 Jul; 41(7):986-994. PubMed ID: 32317755 [TBL] [Abstract][Full Text] [Related]
11. Stimuli-responsive nanodelivery systems for amplifying immunogenic cell death in cancer immunotherapy. Xu W; Liu W; Yang J; Lu J; Zhang H; Ye D Immunol Rev; 2024 Jan; 321(1):181-198. PubMed ID: 37403660 [TBL] [Abstract][Full Text] [Related]
12. Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors. Qi J; Jin F; Xu X; Du Y Int J Nanomedicine; 2021; 16():1435-1456. PubMed ID: 33654395 [TBL] [Abstract][Full Text] [Related]
13. Immunogenic cell death (ICD)-inducers in non-small-cell lung carcinoma (NSCLC): current knowledge and future perspective. Kashefizadeh A; Kazemizadeh H Clin Transl Oncol; 2023 Feb; 25(2):316-322. PubMed ID: 36180811 [TBL] [Abstract][Full Text] [Related]
14. [Immunogenic cell death in hematological malignancies]. Matsushita M Rinsho Ketsueki; 2021; 62(7):709-716. PubMed ID: 34349052 [TBL] [Abstract][Full Text] [Related]
15. Immunogenic cell death in cancer therapy: Present and emerging inducers. Zhou J; Wang G; Chen Y; Wang H; Hua Y; Cai Z J Cell Mol Med; 2019 Aug; 23(8):4854-4865. PubMed ID: 31210425 [TBL] [Abstract][Full Text] [Related]
16. Preconditioning with immunogenic cell death-inducing treatments for subsequent immunotherapy. Pan H; Liu P; Kroemer G; Kepp O Int Rev Cell Mol Biol; 2024; 382():279-294. PubMed ID: 38225106 [TBL] [Abstract][Full Text] [Related]
17. Immunotherapies inducing immunogenic cell death in cancer: insight of the innate immune system. Calvillo-Rodríguez KM; Lorenzo-Anota HY; Rodríguez-Padilla C; Martínez-Torres AC; Scott-Algara D Front Immunol; 2023; 14():1294434. PubMed ID: 38077402 [TBL] [Abstract][Full Text] [Related]
18. Nitric Oxide Induces Immunogenic Cell Death and Potentiates Cancer Immunotherapy. Jiang W; Dong W; Li M; Guo Z; Wang Q; Liu Y; Bi Y; Zhou H; Wang Y ACS Nano; 2022 Mar; 16(3):3881-3894. PubMed ID: 35238549 [TBL] [Abstract][Full Text] [Related]
19. Cu(II) complex that synergistically potentiates cytotoxicity and an antitumor immune response by targeting cellular redox homeostasis. Huang KB; Wang FY; Lu Y; Yang LM; Long N; Wang SS; Xie Z; Levine M; Zou T; Sessler JL; Liang H Proc Natl Acad Sci U S A; 2024 Jun; 121(24):e2404668121. PubMed ID: 38833473 [TBL] [Abstract][Full Text] [Related]
20. A NIR-Light-Activated and Lysosomal-Targeted Pt(II) Metallacycle for Highly Potent Evoking of Immunogenic Cell Death that Potentiates Cancer Immunotherapy of Deep-Seated Tumors. Li C; Tu L; Xu Y; Li M; Du J; Stang PJ; Sun Y; Sun Y Angew Chem Int Ed Engl; 2024 Sep; 63(37):e202406392. PubMed ID: 38775364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]